WIBFF (West Island Brands) Debt-to-EBITDA : -1.03 (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WIBFF West Island Brands Inc WIBFF
30 GF Score
Price $0.00
View Full Analysis

What is West Island Brands Debt-to-EBITDA?

West Island Brands WIBFF -99.97% 30 Debt-to-EBITDA is -1.03 as of Sep. 2022. GuruFocus rates WIBFF with a GF Score™ of 30/100.

Debt-to-EBITDA measures a company's ability to pay off its debt.

West Island Brands's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.42 Mil. West Island Brands's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.83 Mil. West Island Brands's annualized EBITDA for the quarter that ended in Sep. 2022 was $-1.22 Mil. West Island Brands's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was -1.03.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for West Island Brands's Debt-to-EBITDA or its related term are showing as below:

WIBFF's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.67
* Ranked among companies with meaningful Debt-to-EBITDA only.

West Island Brands  (OTCPK:WIBFF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

West Island Brands Debt-to-EBITDA Related Terms

West Island Brands Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for West Island Brands's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Island Brands Debt-to-EBITDA Chart

West Island Brands Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.14 -0.15 -0.35

West Island Brands Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.23 -0.15 -1.37 -1.42 -1.03

WIBFF vs CLSH, NXEN, SNOA: Debt-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, West Island Brands's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

West Island Brands Debt-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, West Island Brands's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where West Island Brands's Debt-to-EBITDA falls into.


WIBFF
30GF Score
West Island Brands Inc WIBFF
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

West Island Brands Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

West Island Brands's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.433 + 0.901) / -3.799
=-0.35

West Island Brands's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.418 + 0.831) / -1.216
=-1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -1.03 mean?
West Island Brands (WIBFF) has a Debt-to-EBITDA of -1.03 as of Sep. 2022. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on West Island Brands.
Is West Island Brands' Debt-to-EBITDA too high?
West Island Brands' current Debt-to-EBITDA is -1.03. Overall, West Island Brands has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does West Island Brands' Debt-to-EBITDA compare to CLSH and NXEN?
West Island Brands' Debt-to-EBITDA of -1.03 can be compared against companies in the Drug Manufacturers industry. The industry median Debt-to-EBITDA is 1.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Drug Manufacturers company?
The median Debt-to-EBITDA among Drug Manufacturers companies is 1.67, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on West Island Brands. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. West Island Brands's current Debt-to-EBITDA is -1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Island Brands stock overvalued right now?
West Island Brands (WIBFF) has a current Debt-to-EBITDA of -1.03. The current Debt-to-EBITDA is -1.03. West Island Brands' overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For West Island Brands (WIBFF), the current Debt-to-EBITDA is -1.03 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

West Island Brands Business Description

Address 44 Victoria Street, Suite No 1102, Toronto, ON, CAN, M5C 1Y2
West Island Brands Inc is a multi-faceted, company in the Quebec cannabis space. A Health Canada Licence Holder West Island has standard cultivation licence, standard processing, medical sales and sales licences.
30GF Score

Get the complete analysis for WIBFF

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price